Literature DB >> 4961992

The Beck operation in the treatment of angina pectoris.

G Sandler, B V Slesser, C W Lawson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4961992      PMCID: PMC471586          DOI: 10.1136/thx.22.1.34

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  Sudden death from coronary disease related to a lethal mechanism arising independently of vascular occlusion or myocardial damage.

Authors:  L ADELSON; W HOFFMAN
Journal:  JAMA       Date:  1961-04-15       Impact factor: 56.272

2.  Some new concepts of coronary heart disease; results after surgical operation.

Authors:  C S BECK; D S LEIGHNINGER; B L BROFMAN; J F BOND
Journal:  J Am Med Assoc       Date:  1958-12-20

3.  Clinical evaluation of pheniprazine in angina pectoris.

Authors:  G SANDLER
Journal:  Br Med J       Date:  1961-03-18

4.  The exercise electrocardiogram in patients with cardiac pain.

Authors:  H G LLOYD-THOMAS
Journal:  Br Heart J       Date:  1961-09

5.  Assay of antianginal agents; the rapport period.

Authors:  S L COLE; H KAYE; G C GRIFFITH
Journal:  J Am Med Assoc       Date:  1958-09-20

6.  Objective evaluation of coronary vasodilator drugs.

Authors:  H I RUSSEK; B L ZOHMAN; V J DORSET
Journal:  Am J Med Sci       Date:  1955-01       Impact factor: 2.378

7.  Operations for coronary artery disease.

Authors:  C S BECK; D S LEIGHNINGER
Journal:  J Am Med Assoc       Date:  1954-11-27

8.  Criteria for the clinical application of the "two-step" exercise test. Obviation of false-negative and false-positive responses.

Authors:  A M MASTER; I ROSENFELD
Journal:  JAMA       Date:  1961-10-21       Impact factor: 56.272

  8 in total
  1 in total

1.  A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.

Authors:  E Marc Jolicœur; Shmuel Banai; Timothy D Henry; Marc Schwartz; Serge Doucet; Christopher J White; Elazer Edelman; Stefan Verheye
Journal:  Trials       Date:  2013-02-15       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.